Posterior uveitis presenting in the context of herpetic retinitis is a distinct clinical scenario that calls for a targeted antiviral approach. This page outlines the key considerations — access the full structured regimen via the link below.
When standard antiviral management is insufficient, treatment may involve a combined antiviral strategy delivered through both systemic and intraocular routes — the specific agents, sequencing, dosing, and monitoring criteria are detailed in the full protocol.
Full regimen, dosages, and algorithm available in the structured protocol →DOI: 10.4103/0301-4738.58470
Long-term systemic antiviral drugs such as acyclovir or valaciclovir are the treatment of choice in case of herpetic retinitis.
In resistant cases, alternatives include a combination of systemic and intraocular antiviral therapy with foscarnet and ganciclovir.
View source ↗